Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-28 5:59 pm Purchase | 2025-05-20 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 175,239,000 6.800% | 175,239,000 (New Position) | Filing History |
| 2025-02-18 4:30 pm Unchanged | 2025-02-10 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-11-20 11:56 am Purchase | 2024-11-14 | 13G | Biodexa Pharmaceuticals Plc BDRX | Brio Capital Master Fund Ltd. | 16,768 0.900% | 11,057 (+193.59%) | Filing History |
| 2024-11-14 5:12 pm Sale | 2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX | Iroquois Capital Management LLC | 11,208 0.670% | -4,471,896 (-99.75%) | Filing History |
| 2024-11-12 4:30 pm Purchase | 2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX | Bigger Capital LLC | 6,926,080 11.000% | 5,959,542 (+616.59%) | Filing History |
| 2024-11-07 4:51 pm Sale | 2024-09-30 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 0 0.000% | -464,781 (Position Closed) | Filing History |
| 2024-08-08 4:24 pm Purchase | 2024-07-19 | 13G | Biodexa Pharmaceuticals Plc BDRX | Iroquois Capital Management LLC | 4,483,104 9.990% | 4,483,104 (New Position) | Filing History |
| 2024-07-23 3:09 pm Purchase | 2024-07-15 | 13G | Biodexa Pharmaceuticals Plc BDRX | Brio Capital Master Fund Ltd. | 5,711 9.830% | 5,711 (New Position) | Filing History |
| 2024-02-14 8:47 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Ionic Ventures LLC | 542 4.900% | 542 (New Position) | Filing History |
| 2024-02-14 2:42 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | ARMISTICE CAPITAL LLC | 100 0.940% | 100 (New Position) | Filing History |
| 2024-02-14 2:14 pm Unchanged | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | CVI Investments Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-13 4:33 pm Purchase | 2023-12-31 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 464,781 9.900% | 22,549 (+5.10%) | Filing History |
| 2024-02-12 4:30 pm Purchase | 2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX | Bigger Capital LLC | 966,538 9.900% | 966,538 (New Position) | Filing History |
| 2024-01-08 4:01 pm Purchase | 2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX | Mercer Street Global Opportunity Fund LLC | 437,587 9.990% | 437,587 (New Position) | Filing History |
| 2023-12-28 4:30 pm Purchase | 2023-12-21 | 13G | Biodexa Pharmaceuticals Plc BDRX | Cavalry Fund I LP | 442,232 9.900% | 442,232 (New Position) | Filing History |
| 2023-03-06 06:01 am Purchase | 2023-02-15 | 13G | Midatech Pharma plc MTP | Ionic Ventures LLC | 4,509,231 9.990% | 4,509,231 (New Position) | Filing History |
| 2023-02-21 11:10 am Purchase | 2023-02-09 | 13G | Midatech Pharma plc MTP | CVI Investments Inc. | 2,708,500 6.200% | 2,708,500 (New Position) | Filing History |
| 2023-02-14 1:50 pm Purchase | 2022-12-31 | 13G | Midatech Pharma plc MTP | ARMISTICE CAPITAL LLC | 96,707 8.930% | 96,707 (New Position) | Filing History |